“Afamelanotide increases pain-free light exposure in adults with EPP.”

Supported with scope

The reviewed evidence supports this exact statement only in the situation described below.

The label and randomized trials support this defined rare-disease outcome.

What this answer is based on

This answer uses a study that assigned people to groups by chance and measured a health outcome.

Limits of this answer

Adults with a history of phototoxic reactions from erythropoietic protoporphyria. These limits show which substance, product, people, use, place, and time the answer covers. A different product or situation can have a different answer.

Topic

What a study measured about people's health, symptoms, or ability to function.